Amr Amin
United Arab Emirates University
158 Papers
216 Citations
Amr Amin is an academic researcher from United Arab Emirates University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 39, co-authored 139 publications. Previous affiliations of Amr Amin include Ain Shams University & Umm al-Qura University.
Chat about Author
Papers
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay,Elizabeth P. Ryan,Graham Pawelec,Wamidh H. Talib,John Stagg,Eyad Elkord,Terry Lichtor,William K. Decker,Richard L. Whelan,H. M. C. Shantha Kumara,Emanuela Signori,Kanya Honoki,Alexandros G. Georgakilas,Amr Amin,William G. Helferich,Chandra S. Boosani,Gunjan Guha,Maria Rosa Ciriolo,Sophie Chen,Sulma I. Mohammed,Asfar S. Azmi,W. Nicol Keith,Alan Bilsland,Dipita Bhakta,Dorota Halicka,Hiromasa Fujii,Katia Aquilano,S. Salman Ashraf,Somaira Nowsheen,Xujuan Yang,Beom K. Choi,Byoung S. Kwon +31 more
TL;DR: The advances made toward understanding the basis of cancer immune evasion are discussed, the efficacy of various therapeutic measures and targets that have been developed or are being investigated to enhance tumor rejection are summarized and some natural agents and phytochemicals merit further study.
1.4K
Broad targeting of resistance to apoptosis in cancer.
Ramzi M. Mohammad,Irfana Muqbil,Leroy Lowe,Clement G. Yedjou,Hsue-Yin Hsu,Liang Tzung Lin,Markus D. Siegelin,Carmela Fimognari,Nagi B. Kumar,Q. Ping Dou,Huanjie Yang,Abbas Samadi,Gian Luigi Russo,Carmela Spagnuolo,Swapan K. Ray,Mrinmay Chakrabarti,James D. Morre,Helen M. Coley,Kanya Honoki,Hiromasa Fujii,Alexandros G. Georgakilas,Amedeo Amedei,Elena Niccolai,Amr Amin,S. Salman Ashraf,William G. Helferich,Xujuan Yang,Chandra S. Boosani,Gunjan Guha,Dipita Bhakta,Maria Rosa Ciriolo,Katia Aquilano,Sophie Chen,Sulma I. Mohammed,W. Nicol Keith,Alan Bilsland,Dorota Halicka,Somaira Nowsheen,Asfar S. Azmi +38 more
TL;DR: This review provides a roadmap for the design of successful anti-cancer strategies that overcome resistance to apoptosis for better therapeutic outcome in patients with cancer.
748
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Mark A. Feitelson,Alla Arzumanyan,Rob J. Kulathinal,Stacy W. Blain,Randall F. Holcombe,Jamal Mahajna,Maria Marino,María L. Martínez-Chantar,Roman Nawroth,Isidro Sánchez-García,Dipali Sharma,Neeraj K. Saxena,Neetu Singh,Panagiotis J. Vlachostergios,Shanchun Guo,Kanya Honoki,Hiromasa Fujii,Alexandros G. Georgakilas,Alan Bilsland,Amedeo Amedei,Elena Niccolai,Amr Amin,S. Salman Ashraf,Chandra S. Boosani,Gunjan Guha,Maria Rosa Ciriolo,Katia Aquilano,Sophie Chen,Sulma I. Mohammed,Asfar S. Azmi,Dipita Bhakta,Dorota Halicka,W. Nicol Keith,Somaira Nowsheen +33 more
TL;DR: Natural compounds found to inhibit one or more pathways that contribute to proliferation have been found and will be very important for identifying signaling pathways and molecular targets that may provide early diagnostic markers and/or critical targets for the development of new drugs or drug combinations that block tumor formation and progression.
662
Tissue invasion and metastasis: Molecular, biological and clinical perspectives.
Wen Guo Jiang,Andrew James Sanders,Masaru Katoh,H. Ungefroren,Frank Gieseler,Mark E. Prince,Sarah K. Thompson,Massimo Zollo,Daniela Spano,P. Dhawan,Daniel Sliva,Pochi R. Subbarayan,Malancha Sarkar,Kanya Honoki,Hiromasa Fujii,Alexandros G. Georgakilas,Amedeo Amedei,Elena Niccolai,Amr Amin,S. Salman Ashraf,Lin Ye,William G. Helferich,Xujuan Yang,Chandra S. Boosani,Gunjan Guha,Maria Rosa Ciriolo,Katia Aquilano,Sophie Chen,Asfar S. Azmi,W N Keith,Alan Bilsland,Dipita Bhakta,Dorota Halicka,Somaira Nowsheen,Francesco Pantano,Daniele Santini +35 more
TL;DR: This review lists the disruption of E-cadherin and tight junctions, key signaling pathways, including urokinase type plasminogen activator (uPA), phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene (PI3K/AKT), focal adhesion kinase (FAK), β-catenin/zinc finger E-box binding homeobox 1 (ZEB
492
Broad targeting of angiogenesis for cancer prevention and therapy
Zongwei Wang,Charlotta Dabrosin,Xin Yin,Mark M. Fuster,Alexandra Arreola,W. Kimryn Rathmell,Daniele Generali,Ganji Purnachandra Nagaraju,Bassel F. El-Rayes,Domenico Ribatti,Yi Charlie Chen,Kanya Honoki,Hiromasa Fujii,Alexandros G. Georgakilas,Somaira Nowsheen,Amedeo Amedei,Elena Niccolai,Amr Amin,S. Salman Ashraf,Bill Helferich,Xujuan Yang,Gunjan Guha,Dipita Bhakta,Maria Rosa Ciriolo,Katia Aquilano,Sophie Chen,Dorota Halicka,Sulma I. Mohammed,Asfar S. Azmi,Alan Bilsland,W. Nicol Keith,Lasse Jensen,Lasse Jensen +32 more
TL;DR: 10 important aspects of tumor angiogenesis and the pathological tumor vasculature which would be well suited as targets for anti-angiogenic therapy are identified and 10 plant-derived compounds could be combined to constitute a broader acting and more effective inhibitory cocktail at doses that would not be likely to cause excessive toxicity.
458